Live Breaking News & Updates on Robert Koremans

Stay updated with breaking news from Robert koremans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Recordati : 28 March 2024 - Directors' Report on item 1 on the agenda – Financial statements approval and allocation of profit -March 28, 2024 at 12:40 pm EDT

This is an English courtesy translation of the original documentation prepared in Italian language

DIRECTORS REPORTS ON THE PROPOSALS ON THE AGENDA OF THE. ....

Robert Koremans , Director Review , Statutory Auditors , Financial Statements , Ordinary General Meeting , Extraordinary Reserve , Chief Executive Officer ,

RECORDATI : APPOINTS MILAN ZDRAVKOVIC AS EXECUTIVE VICE PRESIDENT R&D -October 16, 2023 at 07:53 am EDT

NEWS RELEASE

RECORDATI APPOINTS MILAN ZDRAVKOVIC AS EXECUTIVE VICE PRESIDENT R&D

Milan, 16th October. ....

Matteo Civitali , Robert Koremans , Raffaele Sabia , Global Medical Office , Recordati Rare Diseases Foundation , Novo Nordisk , Italian Stock Exchange , Research Development , Health Economics Outcome Research , Milan Zdravkovic , Executive Vice President , Swedish Orphan Biovitrum , Chief Medical , Medical Affairs , Chief Medical Officer , Health Economics , Outcome Research , Patient Advocacy , Coordination Activity , Rossini Luxembourg ,

Recordati, Zdravkovic vice president R&D and Sabia new CMO

Recordati Spa announced Monday the appointment of Milan Zdravkovic as Executive Vice President of Research & Development. This announcement confirms Recordati s continued commitment to accessible. ....

Rob Koremans , Giuseppe Fabio Ciccomascolo , Raffaele Sabia , Robert Koremans , Novo Nordisk , Recordati Rare Diseases Foundation , Research Development , Alliance News Is Italian Service Ltd , Alliance News , Health Economics Outcome Research , Affairs Department , Global Medical Office , Milan Zdravkovic , Executive Vice President , Swedish Orphan Biovitrum , Chief Medical , Medical Affairs , Chief Medical Officer , Health Economics , Outcome Research , Patient Advocacy ,

Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q2 2022 Results - Earnings Call Transcript

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RCDTF) Q2 2022 Results Conference Call July 28, 2022 10:00 AM ET Company Participants Federica De Medici - Investor Relations &. ....

Giorgio Tavolini , Keyur Parekh , Rob Koremans , Harry Sephton , Bruno Permutti , Intesa Sanpaolo , Robert Koremans , Company Participants , Corporate Communications , Goldman Sachs , Credit Suisse , Investor Relations Corporate Communications , Recordati Industria Chimica , Conference Call July , Chorus Call , Federica De Medici , Investor Relations , Luigi La Corte , Rare Disease , Rare Oncology , Eastern Europe , Magnesio Supremo , North Africa , Specialty Primary Care , East European ,

Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) CEO Robert Koremans on Q1 2022 Results - Earnings Call Transcript

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RCDTF) Q1 2022 Results Conference Call May 10, 2022 10:00 AM ET Company Participants Federica De Medici - Investor Relations &. ....

Rajan Sharma , Giorgio Tavolini , Jo Walton , Anna Murray , Harry Sephton , Robert Koremans , Company Participants , Ministry Of Health , Credit Suisse , Deutsche Bank , Corporate Communications Of Recordati , European Medical Agency , Investor Relations Corporate Communications , Recordati Industria Chimica , Conference Call May , Chorus Call , Federica De Medici , Investor Relations , Corporate Communications , Luigi La Corte , Rare Disease , Primary Care , Eastern Europe , United Statesdollar , Western European , Northern European ,